Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Caralluma edulis extract is a botanical preparation derived from the stem of Caralluma edulis, a succulent perennial herb in the Apocynaceae family. Traditionally used in South Asian medicine for conditions such as hypertension, diabetes, rheumatism, gastric problems, leprosy, and Alzheimer's disease[1][4]. The extract is typically prepared by boiling the stem in water or using hydroalcoholic extraction methods. Pharmacological studies have demonstrated antioxidant, anti-inflammatory (analgesic), anti-obesity[2], antihypertensive[2], anti-atherosclerotic[2], and anti-hyperlipidemic effects. The bioactivity is attributed to phytochemicals including sterols, terpenoids, flavonoids, pregnane glycosides[1][4], saponins and polyphenols. Mechanistically it may act via appetite suppression (possibly through pregnane glycosides) and cell cycle modulation (G1 arrest in pre-adipocyte cells)[5][8]. However clinical efficacy for diabetes reversal has not been established in animal models at tested doses[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Caralluma edulis extract.